US FDA accepts Wockhardt’s new drug application for novel antibiotic Zaynich
The development saw Wockhardt shares up, almost 19 per cent, at ₹1,467 on Monday (2.15 pm)
The development saw Wockhardt shares up, almost 19 per cent, at ₹1,467 on Monday (2.15 pm)